











































Recent advances in the use of stimulated Raman scattering in
histopathology
Citation for published version:
Lee, M, Herrington, CS, Ravindra, M, Sepp, K, Davies, A, Hulme, AN & Brunton, VG 2021, 'Recent
advances in the use of stimulated Raman scattering in histopathology', Analyst.
https://doi.org/10.1039/d0an01972k
Digital Object Identifier (DOI):
10.1039/d0an01972k
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 22. Jan. 2021
Analyst
MINIREVIEW
Cite this: DOI: 10.1039/d0an01972k
Received 5th October 2020,
Accepted 15th December 2020
DOI: 10.1039/d0an01972k
rsc.li/analyst
Recent advances in the use of stimulated Raman
scattering in histopathology
Martin Lee,*a C. Simon Herrington, a Manasa Ravindra,b Kristel Sepp,a,b
Amy Davies, a Alison N. Hulme b and Valerie G. Brunton *a
Stimulated Raman histopathology (SRH) utilises the intrinsic vibrational properties of lipids, proteins and
nucleic acids to generate contrast providing rapid image acquisition that allows visualisation of histo-
pathological features. It is currently being trialled in the intraoperative setting, where the ability to image
unprocessed samples rapidly and with high resolution offers several potential advantages over the use of
conventional haematoxylin and eosin stained images. Here we review recent advances in the field includ-
ing new updates in instrumentation and computer aided diagnosis. We also discuss how other non-linear
modalities can be used to provide additional diagnostic contrast which together pave the way for
enhanced histopathology and open up possibilities for in vivo pathology.
1. Introduction
Diagnosis by histopathology is the clinical gold standard in a
wide variety of diseases but, despite refinement using
immunohistochemical and molecular techniques, remains
limited by the need for tissue removal and laboratory proces-
sing. Whilst tissue sections can often be assessed the following
day after fixation, embedding, cutting, staining and, in some
laboratories, digitisation, there is a need for more rapid and
accurate diagnostic processing in the operating room. To help
guide resection of diseased tissue during an operation,
especially where an unexpected finding may require modifi-
cation or even termination of the surgery, an intra-operative
diagnosis of the tissue may be performed. Time in the operat-
ing theatre is an expensive commodity so a rapid approach to
obtaining a reliable diagnostic slide is taken in the form of a
frozen section of tissue stained with haematoxylin and eosin
(H&E). Concordance of frozen section histopathology to per-
manent formalin fixed sections is typically very high,1 though
there are a number of potential limitations around sample pro-
cessing that may cause difficulty in diagnostic interpretation.
Technical issues, particularly in challenging tissue types such
as brain matter, are introduced when samples are frozen,
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which can lead to bloated cell morphology, uneven sectioning
and poor staining.2,3 Whilst turn-around times are often
reported in the region of 20 minutes this is the time taken for
a pathologist to assess the specimen and excludes tissue trans-
port and preparation time.4 These steps also require highly
trained technical personnel and facilities which add further
costs to the endeavour so there is great interest in providing
new, adjunctive, tools for use in this environment.
The ability to produce ‘H&E-like’ images using optical
approaches can reduce, or potentially eliminate, the costs
associated with laboratory processing whilst maintaining the
information provided by this gold-standard staining method.
Moreover, the additional chemical information provided by
optical methods such as stimulated Raman scattering (SRS)
can enhance the information generated from the tissue.
Whilst it could be argued that there is a cost-shift associated
with training other professionals to interpret the images, par-
ticularly those generated in the operating room, the involve-
ment of pathologists in the interpretation of the images can be
achieved easily by remote viewing of digital images. In
addition, any additional costs must be balanced against the
cost savings associated with reduced laboratory processing,
which involves complex laboratory equipment and reagents,
and multiple professional groups. The reduction in time taken
to produce the images also provides significant advantages in
terms of reduction in anaesthetic time and improved operating
theatre efficiency. Finally, the generation of images in ‘real-
time’ allows a more interactive approach, particularly to intra-
operative diagnosis, where surgeons and pathologists can col-
laborate iteratively to solve a particular clinical problem. This
can be a significant problem particularly when assessing
tumour resection margins, where multiple specimens need to
be sent from the operating theatre to the laboratory, com-
pounding the time taken to achieve an appropriate outcome
for the patient. The generation of serial optical images,
without the need for specimen transport or processing, would
be a significant advance, with even greater reduction in anaes-
thetic time and improvement in operating theatre efficiency.
Vibrational spectroscopy has long drawn interest as a diag-
nostic tool for differentiating normal and diseased tissue by
assessing changes in the chemical composition via the inter-
action with light. Typically, two approaches to vibrational spec-
troscopy can be taken, infrared (IR) spectroscopy, where the
absorbance of light is measured, or Raman spectroscopy
where the inelastic scattering of photons are measured. Both
techniques have been explored as potential diagnostic markers
for a wide variety of diseased states but their use in imaging
applications is limited by the relatively long acquisition
times.5 Biological Raman spectra are usually divided into three
distinct regions as show in Fig. 1A: a high frequency region,
often called the C–H stretch region between 2800 and
3200 cm−1 mainly containing broad C–H and O–H bond
vibrations; a silent region between 1700 and 2800 cm−1 where
no cellular vibrations occur and a fingerprint region between
500 and 1700 cm−1 that contains many overlapping peaks
used to identify biochemical information associated with pro-
teins, lipids and DNA.
The development of coherent Raman imaging (CRI) and
particularly stimulated Raman scattering (SRS) however has
opened the door for vibrational imaging at a speed and resolu-
tion that can start to compete with optical methods. SRS uses
two lasers that are separated in frequency to generate a stimu-
lated emission when the frequency difference matches a
Raman vibrational mode of interest. By modulating one of the
lasers in amplitude this stimulated emission can be measured
in the other at the modulation frequency using a lock-in
amplifier. SRS is not affected by fluorescence from the sample
and the signal closely resembles that of spontaneous Raman
whilst being linearly correlated with the concentration of indi-
vidual vibrational motifs, allowing quantitative analysis.6
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The abundance of CH, CH2 and CH3 stretches from pro-
teins and lipids in the high-frequency region generates strong
contrast allowing rapid image acquisition. The differing
chemical composition of these macromolecules give rise to
subtly differing spectra in this region, with proteins typically
showing a peak around 2930 cm−1 due to higher CH3 content
and lipids showing a peak around 2850 cm−1 due to their CH2
content. Images at these wavelengths (Fig. 1B and C) highlight
different features of the cell which can be further enhanced
through image subtractions. Typically, the CH2 contrast is
used to highlight cytoplasmic features whilst a difference
image of the two wavelengths highlights the nuclei of the cells
(Fig. 1D and E). By applying colour look up tables (LUTs) an
image can be produced to mimic familiar H&E staining as
shown in Fig. 1F.7 Technical details of the methods behind
this process are summarised in two excellent reviews from
Camp et al.,8 and Yang et al.,9 whereas this review will update
on the current clinical applications of SRH.
Multiphoton techniques, such as CRI, are attractive due to
the potential advantages that they offer over traditional histo-
pathology methods in terms of time and resource saving. The
ability to generate contrast without the need for staining and
an inherent optical sectioning ability allows them to be used
on unsectioned tissue biopsies without any further processing.
By bringing CRI to the operating theatre, there is potential for
a new, rapid pathway compared to conventional frozen sec-
tions as shown in Fig. 2. This allows for operator agnostic his-
topathological details to be viewed directly from excised tissue
Fig. 1 Generation of SRH images. (A) Raman spectra of a typical cell showing the location of the fingerprint, silent and C–H stretch regions. Images
of HeLa cells at (B) CH2 stretching vibration at 2840 cm
−1, (C) CH3 stretching vibration 2930 cm
−1, (D) thresholded CH3-CH2 difference image, (E)
composite image generated from (B and D) with green channel showing the cell body and blue channel highlighting nuclear morphology, (F) reco-
loured image of (E) to mimic H&E staining colours. Scale bar 10 μm. Images captured at 1024 × 1024 with 20 μs pixel dwell time with a frame time of
22.3 s per image.
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within minutes. Moreover, these images can be shared across
networks allowing intraoperative consultation with either diag-
nostic algorithms or remote experts as required.
2. Stimulated Raman histopathology
in the operating theatre
Whilst laboratory-based SRS systems are often designed with
little regard for space requirements, stability or user experi-
ence, clinical systems will have stricter design limitations as
well as the need to focus on costs. Clinical applications will
generally come in one of two formats: imaging previously biop-
sied material or an in situ scanning device designed to image
from either an exposed surface or endoscopically from the
patient.
Biopsy imaging systems designed for use in a clinical
setting are already involved in many of the trials reported on
in this review.10–12 The design shares many similar com-
ponents to those found in a lab with the sample being
scanned by a traditional microscope objective and the sample
housed on a moving stage to allow large areas of tissue to be
collected (this setup is shown in Fig. 4A). The divergence
occurs from the need to construct a system that requires no
adjustments to maintain alignment over both long-term use
and with shocks that might come from moving equipment
around as needed. A fibre laser has been shown to be a
good candidate to replace optical parametric oscillators as
they are comparatively inexpensive and the difference fre-
quency of the two major fibre gain media, Erbium and
Ytterbium, correspond to the high-wavenumber region of
Raman spectra used in SRH. Light guided through a fibre
core also avoids misalignments that can be introduced by
free space optics in uncontrolled environments. Fibre lasers
do exhibit more high frequency laser noise though, but it
has been demonstrated that this can be removed using an
Fig. 2 Intraoperative workflows of both conventional H&E staining histopathology and SRH with computer aided diagnosis. (A) Small freshly excised
specimens can be imaged directly in the operating theatre. (B) CH2 and CH3 images are aligned and processed to provide inputs for a convolutional
neural network (CNN). (C) The CNN classifies regions of the images as either normal, tumour or as unknown. This process can produce results in
under 2.5 min from a 1 mm2 sample, compared to the frozen section route that may take over 30 minutes (and may require larger specimens) and
relies on the presence of a trained pathologist.
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autobalanced detection scheme to achieve shot noise sensi-
tivity.13 A final consideration is the need to package the
device into a portable self-contained unit that can be moved
around and disinfected as required. Orringer et al.,14
reported that their test system was able to remain in oper-
ation in a clinical environment service-free without the
need for realignment for years, including shipping across
states.
Imaging in situ is a greater challenge requiring a complete
redesign of the optics involved to allow them to move to the
area of interest, it also requires an epi-detection setup due to
the impracticality of collecting transmitted light in most con-
ditions. epi-Detection has been demonstrated in a single fre-
quency system in vivo by using a polarising beam splitter and
quarter wave plate to separate the backscattered laser light.15
Bae et al.16 showed that using an epi-detection setup they
could differentiate glioblastoma subtypes in bulk brain tissue
with hyperspectral SRS imaging.
A simple model of a handheld SRS system created by Liao
et al.,17 used a photonic crystal fibre to connect the output of a
laser to a handheld combined scanhead and lens which could
then be moved to the subject rather than vice versa allowing
for measurements from exposed surfaces. Ultimately endo-
scopic probes could be used to allow SRS histopathology diag-
nosis rather than requiring biopsy material, however this is a
difficult challenge due to the need to carry two spatially and
temporally overlapped pulses in a flexible fibre. Lombardini
et al.18 demonstrated that by using a hollow-core Kagomé-
lattice double-clad fibre that the parasitic signals usually gen-
erated within other fibre types due to mixing of the two laser
pulses were greatly reduced. Coupled with a set of minia-
turised optics this created a 4.2 mm wide probe that allowed
for Coherent Raman images to be taken with a sub-micron
resolution and a 320 µm field of view, and with further devel-
opment could be optimised for SRS imaging.
2.1 Clinical trials of the NIO system
Orringer et al.14 conducted the first application of SRS in an
operating room using a custom designed system built in col-
laboration with Invenio Imaging, which later developed into
the NIO imaging system. Having previously developed a meth-
odology for SRH, this study demonstrated that they were
capable of transferring SRH to the theatre by imaging fresh
surgical specimens from central nervous system (CNS)
tumours. A trial using 101 neurosurgical patients established
that they were able to recapitulate the H&E like stain on fresh
tissue by squashing the sample between slide and coverslip.
Comparisons between H&E and SRH images from the NIO
Imaging system are shown in Fig. 3. Using only two wave-
lengths in the C–H stretching region (2930 and 2845 cm−1)
they showed that key differences in cellularity, vascular pattern
and nuclear architecture were visible and could be used to dis-
tinguish tumours. 30 of the patients who had undergone
intraoperative diagnosis were enrolled in a study to assess the
concordance among pathologists who compared adjacent por-
tions of the same specimen that had undergone SRH and
frozen section H&E staining. Using SRH pathologists were very
accurate in distinguishing lesional from non-lesional tissues
(98%), glial from non-glial tumours (100%), and predicting
diagnosis (92.2%). Diagnostic discrepancies were thought to
be due to the different appearance of nuclear atypia and
mitotic features between the two techniques.
Orringer and colleagues led a further trial on 20 paediatric
brain tumours.10 Using the intraoperative pathological diagno-
Fig. 3 Comparison of formalin-fixation, paraffin-embedding, H&E-stained images and SRH in selected tumours. SRH reveals architectural differ-
ences between a shallow tissue biopsy (green headings) where disorganized binucleated dysplastic neurons predominate, and a deeper biopsy (blue
headings), where architecture is more consistent with a hypercellular glioma. Adapted and reproduced from ref. 14 with permission from Springer
Nature Publishing Group, copyright 2017.
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sis as ground truth both SRH and frozen section H&E images
provided accurate diagnosis (SRH, 92–96%; H&E 92–100%).
SRH images highlighted a number of unique features that
could aid diagnostics such as high intracellular lipid content
in the cytoplasm of tumour associated macrophages and well
visualised axons that help differentiate between infiltrative and
well-circumscribed tumours. SRH was shown to avoid some
tissue processing artefacts associated with freezing that dis-
rupted cytological features.
Eichberg et al.11 led a study whose main objective was to
compare the time difference between using the onsite SRH
imaging system with that of frozen section analysis. The study
compared a variety of CNS tumour types with SRH generated
images and produced a time to diagnosis (from specimen
removal) that was 30 (±13) minutes quicker than that of frozen
section analysis whilst achieving the same diagnostic corre-
lation of 91.5% to permanent sections. The inclusion criteria
did mean that well-circumscribed and obvious tumours were
included which would not normally require consultation.
The largest trial utilising the NIO Imaging system to date
was reported by Hollon et al. consisting of a multi-centre non-
inferiority clinical trial of brain tumour diagnosis in 278
patients.12 Diagnostic accuracy of a CNN diagnosis from SRH
images was compared with conventional frozen section or
smear techniques. Final clinical diagnosis was used as ground
truth with the SRH arm providing a slightly higher overall
accuracy (264/278) than the control arm (261/278).
Interestingly of the 17 errors in the control arm, SRH images
correctly classified all of them, whilst the reverse was true of
the 14 cases for SRH. Details of the clinical trials carried out
with the NIO system are summarised in Table 1.
3. Advances in imaging technology
The NIO system has been vital in showing that SRH is possible
in an operating theatre environment but there are a number of
potential pathways to increase the imaging speed by altering the
optical design which allows faster imaging, as shown in Fig. 4B.
Heuke et al. designed a system that expanded a typical SRS
setup with another optical parametric oscillator (OPO) creating
a second independently tunable pump beam that can be used
over the full range of molecular vibrations.19 By modulating at
a second frequency, multiple lock-in amplifiers can separate
the individual signals from a single Stokes beam. A modifi-
cation of this setup was used by Sarri et al.7 to record a differ-
ence image between the 2930 cm−1 and 2845 cm−1 frequencies
as a frequency modulated (FM) SRS technique alongside coher-
ent anti-Stokes Raman scattering (CARS) to provide the second
Raman shift wavelength. This setup halved the acquisition
time compared to sequential scanning.20
Using a third laser can be an expensive solution and
increases the complexity of alignment and optical design. He
et al. showed that you could also create an image at a second fre-
quency using a broadband femtosecond laser with spectral
focusing.21 In this setup the Stokes beam was split by a polaris-
ing beam splitter to create a second Stokes beam. By careful
manipulation of the optics, this second Stokes beam was phase
shifted so that the induced modulation could be picked up as
the quadrature component of a lock-in amplifier. By using a
longer duration pump pulse, the Stokes laser could interact with
both the CH2 and CH3 frequencies with little cross talk, also
halving the time required for imaging. Another advantage of
using broader pulses was shown by Francis et al.22 who investi-
gated the optimal laser pulse width. As the pulse widths became
broader they found the signal-to-noise ratio increased due to the
broad peaks in the C–H stretch region. Subsequent unmixing of
the images showed only small decreases in contrast.
Using a broadband laser can also be used to capture simul-
taneous spectral data by using a grating to project the broad-
band pulses onto an array of detectors. Huang et al. used a 32
element photodiode array to allow them to record channels
with a spectral resolution of 13.4 cm−1.23 Using an unsuper-
vised algorithm they were then able to cluster cellular compart-
ments based on their signature Raman spectra. Although this
approach was used for cytometry it could also be applied to
pathological tissue samples.
When scanning large tissue samples the tiling of fields of
view together is very inefficient due to the need to scan over-
lapping regions required for image stitching. This stop-start
method of scanning also adds downtime due to the need to
Table 1 Results from clinical trials of the NIO system
Study DOI Year Sample size Diagnosis Critera evaluated SRH vs. permanent section accuracy
10.1038/s41551-016-0027 2017 30 Human Lesional from non-lesional 98%
Glial from non-glial 100.0%
Predicting diagnosis 92.2%
Computational Lesional from non-lesional 100%
Glial from non-glial 90%
Predicting diagnosis 90%
10.1158/0008-5472.CAN-17-1974 2018 25 Human Lesional from non-lesional 97.3%
Low-grade from high-grade 98%
Predicting diagnosis 93.3%
Computational Lesional from non-lesional 93.8%
Low-grade from high-grade 89.4%
10.3171/2019.9.JNS192075. 2019 82 Human Lesional from non-lesional 97.5%
Predicting diagnosis 91.5%
10.1038/s41591-019-0715-9 2020 278 Computational Predicting diagnosis 94.6%
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move the sample and re-initialize the system. Zhang et al.,24
introduced a strip mosaicing method where strips of the
sample were scanned in a continuous fashion by translating
the sample whilst the scan mirrors operate in 2D. This
reduced the scanning downtime and when combined with
their dual phase detection, reduced the imaging time for the
whole brain from 70 to 8 minutes.
Hyperspectral imaging, where many different wavelengths
are scanned to build up SRS spectra could be used to measure
more subtle shifts in the vibrational spectra which have tra-
ditionally been used for spontaneous Raman diagnostics of
tumours.25 Whilst manually tuning a laser is possible, this
approach is often time consuming and so the selective filtering
of a broadband source is often preferred. Alshaykh et al., used
a combination of acousto-optic programmable dispersive
filters and a spectral focusing method to scan a spectral width
of 200 cm−1 which covers the C–H stretch region almost com-
pletely in 12.5 µs.26 Audier et al.,27 subsequently showed that
using this technique on biopsy samples could generate images
with suitable quality for SRH. Further utilisation of the spec-
tral data encoded in each pixel could allow for far more
detailed feature extraction to be carried out than image reco-
gnition algorithms alone are capable of.
4. Quantitative imaging
Quantification of Raman signals with SRS is possible as there
is a linear dependence of the signal intensity with chemical
concentration, however, this can be hampered and due to irre-
gular light scattering within the tissue, as well as overlapping
chemical species. Oh et al.,28 developed a technique they
termed Normalized Raman Imaging (NoRI), to computation-
ally remove the effect of tissue light scattering during spectral
decomposition to calculate the absolute concentrations of cel-
lular components. By assuming that the sum of protein, lipid
Fig. 4 Advances in SRS imaging technology. (A) Experimental setup of a single frequency SRS system with epi detection of other signals. A modu-
lated Stokes beam and pump beam are directed on to a sample, with the forward scattered light being filtered and demodulated by a lock-in
amplifier to generate SRS signals. Back scattered light can be used to generate images for other non-linear imaging modalities. (B) Methods for sim-
ultaneous multifrequency imaging with SRS include using the third laser modulated at a second frequency and two lock in amplifiers. For dual phase
detection, the Stokes beam is split into two with them being modulated with a 90° phase difference. The SRS signals can then be detected as the in-
phase and in-quadrature components of the lock-in amplifier. Finally, multiple Raman modes can be detected simultaneously by using a diffraction
grating to disperse a broadband pump beam onto a 32-channel photodetector array.
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and water was constant in a tissue sample the attenuation
caused by the sample itself could be removed. Following linear
decomposition of SRS scans taken at methyl, methylene and
oxygen–hydrogen stretching peaks, the sum of these three
components also serves as the normalisation mask for the
tissue. The decomposition process was calibrated using bovine
serum albumin, dioleoyl-phosphocholine and pure water as
the standards for protein, lipid and water respectively, with
mass concentrations estimated by multiplying the volume frac-
tion of the components with an estimated density of pure
protein, lipid or water. The method was validated by compar-
ing NoRI calculations against known concentrations of BSA
solutions, and in situ NoRI quantification of total protein and
lipid mass density in chondrocytes. This showed good agree-
ment with dry mass density measured by refractive index tom-
ography, although small differences could also be explained by
the contribution of other chemical species such as nucleic
acids or glycoproteins which are not accounted for. Apart from
acquiring high quality contrast for the identification of a
variety of histological features in mouse cerebellum and pan-
creas, the utility of NoRI in quantitative histopathology was
demonstrated by imaging the brain of mice from a model of
Alzheimer’s disease, where protein rich amyloid plaques were
visualised in the extracellular space, surrounded by high lipid
concentration, which were distinct from the patterns of
protein and lipid organisation observed in normal mouse
brain.
5. Computer aided diagnosis
Computer aided diagnosis (CAD) is well integrated in radiology
but its adoption in histopathology has been slower.29 While
CAD is used to diagnose the presence of a tumour, histo-
pathology is required to classify such tumours and inform the
course of treatment, consequently requiring more complex
systems. Furthermore, the use of CAD in histopathology
requires digital images but histopathology has traditionally
relied on the pathologist viewing glass slides at the micro-
scope. Recently advances have been made with the introduc-
tion of whole slide imaging (WSI) and digital pathology and its
adoption in some hospitals for all primary histopathological
diagnosis.30,31 With the increased use of digital pathology,
machine learning (ML) approaches to classifying histopatholo-
gical samples are being investigated as reviewed by Komura
et al.32 The motivation for developing automated processes for
interpreting slides is driven by a shortage of specialist pathol-
ogists and the potential to decrease the time to determine a
preliminary diagnosis as discussed above.7,33,34 The large data
sets generated from SRH can lend themselves to ML
approaches to rapidly classify tissue. Orringer et al., have devel-
oped ML approaches to enable automated diagnosis of CNS
tumours from their SRH images – as reviewed by Khalsa
et al.35 Their approach has evolved from using vector-based
multilayer perceptron (MLP) which are trained using special-
ised knowledge of CNS tumours to manually define important
features (nuclear morphology, cell density, vascularity, etc.)
and can result in biasing of data,10 to using deep CNN that
retain spatial information and learn what image features are
important in determining diagnosis and predicting patient
outcomes.12
All ML approaches require access to large numbers of
classified and unclassified images to train the networks.
However, once trained deep neural networks have been shown
to accurately differentiate neoplastic specimens from normal
tissue in laryngeal squamous cell carcinoma36 and in brain
tumours (Fig. 5) and to have a diagnostic accuracy of 94.6%,
comparable with H&E samples used by specialist pathologists
at 93.9%.12 Interestingly, Hollon et al.,12 found that the CNN
correctly classified those misclassified by pathologists and
pathologists correctly classified those misclassified by the
CNN, which suggests that pathologists aided by automated
classification systems will improve diagnostic accuracy, par-
ticularly in difficult cases. Additionally, insight into important
features used to classify images can be extracted latterly from
the classification programme.
6. Beyond H&E
Shin et al., highlighted some of the limitations of using just
SRH for the detection of complex pathologies.34 Assessing a
broad range of skull base tumours, where cytoarchitecture can
be lost during freezing and sectioning, pseudo-H&E coloured
SRH images achieved a relative accuracy of 87% compared to
permanent sections. The high accuracy was mainly driven by a
large number of easy to diagnose meningiomas. Other tumour
types like chondosarcoma (0% accuracy) and schwannoma
(44% accuracy) proved more challenging due to the absence of
H&E features in the SRH images. The authors posited that in
some tumour types lipid and protein contrast did not offer
enough diagnostic features. By imaging at other SRS frequen-
cies or using more label-free imaging modes additional diag-
nostic contrast can be added to images than just revealed by
CH3/CH2 imaging alone. Some of these virtual ‘stains’ that
either have been used in conjunction with SRH or could easily
be added due to the similarity of microscope setup are dis-
cussed below and summarised in Fig. 6.
6.1 Second harmonic generation and other non-linear
modalities
A number of studies have incorporated the use of second har-
monic generation (SHG) to visualise collagen fibres within
tissue samples. For example, working on laryngeal cancers
Zhang et al.,36 first compared 80 pairs of frozen sections
imaged with SRS at the CH2 and CH3 wavelengths and SHG,
with H&E staining to demonstrate that pathologists could use
the combined SRH and SHG images for diagnosis with high
accuracy (94.2% vs. 94.6% accuracy SRH vs. frozen section
H&E). Unlike other work, the SRH images were not pseudo-
coloured to an H&E like stain but a brief overview was given to
the pathologists. Like Hollon et al.,12 a CNN was trained on 45
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fresh samples from patients and used to classify 33 indepen-
dent surgical specimens with 100% accuracy compared to
standard H&E paraffin sections.
A saffron stain, which marks collagen in connective tissue,
can be added to an H&E stain (HES) to image gastrointestinal
tumours as the macro and microscopic organisation of col-
lagen can be an important indicator of cancer development
and also help to guide intraoperative decision making. Sarri
et al.,33 presented direct one-to-one comparisons of cryosec-
tions imaged first by SRH and SHG, then processed for HES
staining. The combined SRH/SHG images were recoloured
with look-up tables used to match those that are produced
with traditional staining. SHG and SRH were coloured orange,
pink and dark purple to match saffron, eosin and haematoxy-
lin staining. The recoloured images showed a high image cor-
relation coefficient to the HES images, with differences often
attributed to the inherent sectioning ability of SRH or slight
variations in colouration. Features that were characteristic of
both healthy areas of tissue and dysplasia could be readily
visualised and although the intrinsic SRH z-sectioning ability
was responsible for a few missing nuclei compared to HES, the
overall image was sharper.
In addition to recording SHG images simultaneously, SRS
microscope setups are often amenable to collecting other
label-free non-linear signals that could be used to provide
more contrast for the area being scanned. Whilst using fre-
quency modulation-SRS (FM-SRS) to image nuclei, Sarri
et al., were able to use either coherent anti-Stokes Raman
scattering (CARS) or two-photon auto fluorescence to image
the cellular body.7 Although CARS exhibits a non-resonant
background which usually makes SRS preferable, the signal
from the C–H stretch region is well defined and provides a
strong backwards scattered signal that can be more easily
detected in thick samples.
Autofluorescence from the cell is typically from oxidative
chain respiratory proteins NADH and FAD and high levels of
NADH have been associated with glycolysis or regions of
hypoxia.37,38 Bower et al., have demonstrated that incorpor-
ation of fluorescence lifetime imaging microscopy (FLIM) is
able to separate free and bound NADH in living samples, and
developed a video rate FLIM system which could add infor-
mation on metabolic activity to the images.39
6.2 Imaging in the C–H region
6.2.1 DNA Imaging. Imaging DNA in the fingerprint region
has previously been reported but only in cells with condensed
chromatin/chromosomes to allow sufficiently concentrated
DNA to generate an SRS signal.40 An approach that would
Fig. 5 Example of SRS histopathology using a CNN (ResNet 34) to aid with diagnosis. (a) Full SRH mosaic of a brain-tumour interface of a patient
diagnosed with glioblastoma. (b) Dense hypercellular glial tumour with nuclear atypia is seen diffusely on the left and peritumoral gliotic brain with
reactive astrocytes on the right of the specimen. (c) Three channel RGB CNN prediction transparency overlaid on the SRH image. (d) Associated
patient level diagnostic class probabilities. (e) Inference class probability heatmaps for tumour, non-tumour and non-diagnostic regions within the
SRH image. Adapted and reproduced from ref. 12 with permission from Springer Nature Publishing Group, copyright 2020.
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allow DNA imaging even in interphase was later demonstrated
by using a distinct spectral feature of DNA in the C–H stretch-
ing region which when coupled with linear decomposition
allowed a higher sensitivity DNA imaging than that found in the
fingerprint region which could help add better nuclear mor-
phology and architecture than current SRH techniques.15 Hill
et al.,41 were able to further enhance imaging of DNA within
this region by using a polarisation encoded FM-SRS technique
designed to isolate spectral contributions from low-signal
species. By tuning the frequency difference so that there is a
roughly equivalent contribution of protein at each vibrational
transition measured during the frequency modulation it can be
cancelled out, highlighting any contribution from DNA C–H
stretches in the ‘on-resonance’ portion.
6.2.2 Imaging silicone implants. Currently, silicone detec-
tion in histopathological slides from women with silicone
breast implant failures relies on morphological features.
Haasterecht et al., developed an SRS technique to specifically
detect micrometer (≥2 μm) sized polydimethylsiloxane (PDMS;
the filling of modern implants) fragments that have a C–H
stretch vibrational frequency at 2905 cm−1 which is distinct
from that of the major tissue constituents.42 Histopathological
Fig. 6 Overview of the different imaging ‘stains’ that multimodal histology can provide. Stimulated Raman Scattering in the C–H stretch region can
image (A) cytoplasm and organelles of cells using the CH2 stretch, (B) isolated nuclei using the difference of CH3 and CH2 images, (C) silicon from
implants (image reproduced from ref. 42 with permission from Wiley Online Library, copyright 2020). Imaging in the fingerprint region can show (D)
build-up of amyloid plaques (image reproduced from48 with permission from Springer Nature Publishing Group, copyright 2015), or (E) the for-
mation of calcifications (image reproduced from ref. 47 with permission from Ivyspring International, copyright 2020). Imaging in the silent region
can allow (F) the direct visualisations of alkyne containing drugs such as ponatinib. Using multiphoton imaging can give details on (G) autofluores-
cence life-time imaging for metabolic tissue profiling (two-photon-excited fluorescence: TPEF), as well as (H) SHG imaging to image collagen fibres.
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samples collected following removal of failed implants identi-
fied large aggregates of PDMS. In one case, localization within
vacuoles was detected in an enlarged axillary lymph node from
a patient with a ruptured implant. Deparaffinised H&E stained
slides did not interfere with the SRS signal for silicone
distribution and quantification. It is anticipated that the
scope of this technique can be broadened to thicker
samples and simultaneous tissue component analysis for
improved pathophysiological understanding of silicone
implant failures.
6.3 Imaging in the silent region
The absence of any competing inherent biological signals
allows SRS to be used to image relatively low concentrations
of molecules that contain Raman peaks in the silent region.
Whilst this has usually been used to add a small Raman
active label such as an alkyne to a target molecule43,44 there
are a number of clinical drugs that already contain this
bond in their structure. Sepp et al.,45 were able to image
ponatinib, an alkyne containing tyrosine kinase inhibitor
used to treat chronic myeloid leukaemia at biologically rele-
vant concentrations. This demonstrates a potential to visual-
ise drug distributions within tissues simultaneously with
SRH.
6.4 Imaging in the fingerprint region
There is a Raman spectral change in the amide I band (to
1670 cm−1) of the β-sheets within misfolded proteins that form
in amyloid plaques, compared to native proteins (1658 cm−1).
The deposition of amyloid plaques is a hallmark of
Alzheimer’s disease and this allowed Ji et al. to rapidly detect
and quantify misfolded amyloid plaques in brain tissue taken
from a mouse model of Alzheimer’s disease. Using a hyper-
spectral picosecond narrow band laser-based SRS set up to
collect images at three Raman frequencies (1640, 1658, and
1670 cm−1), together with a linear decomposition algorithm,
allowed extraction of spectral information from misfolded pro-
teins in the fingerprint region. Interestingly, unlike other
imaging methods, three-color SRS revealed that the plaques
are surrounded by lipid-rich halo structures whose relation-
ship with the pathophysiology of amyloid plaques is yet
unknown. Fresh tissue samples gave the best images, as tissue
processing induced protein conformational changes that
reflected directly on the amide I spectral signature.46
Shin et al., demonstrated the clinical value of hyperspec-
tral SRS imaging for breast cancer diagnosis via provision of
spatially resolved qualitative and quantitative information on
tissue calcification.47 A broadband femtosecond dual-beam
laser system was used to quantify the carbonate content of
hydroxyapatite, the main calcification species associated with
cancer. The ratio of carbonate (∼1070 cm−1) to phosphate
(∼960 cm−1) peaks mapped the intra- and inter-tissue calcifi-
cation heterogeneity among breast cancer tissue samples. A
variety of calcifications were identified whose chemical com-
position could be correlated to the local malignancy, degree
of advancement and type of breast cancer. SHG was incor-
porated to visualize calcified organic matrix components to
bridge the information gap where carbonate content was
insufficient for diagnosis such as the differentiation between
fibroadenoma and invasive ductal carcinoma. Of a total 214
breast calcifications imaged for separating benign from neo-
plastic processes, >85% sensitivity and specificity were
reached. The feasibility for combining calcium imaging and
SHG with SRH will enable comprehensive diagnosis and
potentially minimize inter-pathologist discordance for
effective prognosis.
7. Correlated imaging with SRS
histopathology
As SRS histopathology only involves light interacting with the
sample, and no sample preparation steps, it is well placed to
be used alongside other analytical processes that require
unprocessed tissue. This can either be done on the same piece
of tissue, or using an adjacent section where correlation of fea-
tures is eased due to the lack of distortions introduced during
normal tissue processing. Randall et al.,49 co-registered SRS
histopathology images of brain slices with a serial section
using quantitative MALDI-MSI by an automatic t-distributed
stochastic neighbour embedding based registration method to
image the distribution of the tyrosine kinase inhibitor erloti-
nib. Images showed that the protein rich tumour core con-
tained higher drug concentrations but the tumour edge had
an inverse relationship between higher lipid content and drug
content. Erlotinib showed limited diffusion across regions of
intact blood brain barrier within regions of normal brain
matter.
8. 3D histopathology
Current histopathological techniques rely on the examination
of thin (5 µm) sections for light microscopy, with fewer than 5
sections typically examined during a frozen section procedure.
Imaging the whole volume of a centimetre-sized tissue block
would require the examination of 2000 serial sections, which
is not feasible. Imaging the tissue block by sectioning it into a
few thicker slices (250 µm–2 mm) would allow the generation
of 3D images, removing the inherent sampling error of the
conventional approach and potentially identifying focal
abnormalities not present in the initial, superficial, sections.
As SRS imaging requires no labelling, this would also save
time and resources during sample preparation, and avoid vari-
ation in staining intensity among traditionally labelled slices.
The most limiting factor of imaging in 3D using SRS
microscopy is imaging depth. Hill et al. explored SRS imaging
depth in four different tissue types – brain, kidney, liver and
lung.50 Using ex vivo murine samples at 1 mm thickness, they
determined maximum imaging depths for each tissue type
(kidney 165 µm, liver 170 µm, brain 185 µm, lung 70 µm).
Lung tissue had the poorest penetration depth (70 µm), due to
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its strong light scattering properties. For brain tissue, they also
compared penetration depth with varying sample thickness
(250 µm, 500 µm, 1 mm, 2 mm), and found that sample thick-
ness plays a role in how deep SRS can image. Penetration
depth was best for thinner samples (205 µm for 250 µm
sample) and decreased as sample thickness increased (130 µm
for 2 mm sample).
To improve penetration depth, Li et al., optimised tissue
clearing methods in brain samples.51 Using formamide as a
clearing agent improved SRS imaging depth and allowed pene-
tration up to 500 µm in brain slices. The same method was
also successfully applied to kidney, liver and lung tissue
imaging. This demonstrates that SRS can be successfully used
in 3D histopathology. However, further research is required to
explore how the 3D data could be used to add value in
pathology.
9. Conclusions and future
perspectives
Conventional histopathology methods are limited by the
requirement for time-consuming and expensive laboratory pro-
cessing, and are restricted to the analysis of thin 2D sections
by light microscopy. Optical imaging methods based on
Raman scattering offer the prospect of not only generating
equivalent information using a label-free approach but also
producing additional information based on chemical signa-
tures and 3D structure. Coupled with artificial intelligence
approaches that can derive molecular information from histo-
pathological images,52 this paves the way for enhanced histo-
pathology by providing pathologists with additional diagnos-
tics tools. This has the potential to enhance patient outcomes,
the former through improved diagnostic accuracy and the
latter by obviating the need for tissue biopsy, with consequent
improvement in clinical efficiency.
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